Induction of the peroxisome proliferator activated receptor by fenofibrate in rat liver

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302

Molecular Cloning: A Laboratory Manual

Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1006/abio.1987.9999 · Cited by 65,515

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Towbin, H., Staehelin, T., & Gordon, J. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.9.4350 · Cited by 53,218

Primer-Directed Enzymatic Amplification of DNA with a Thermostable DNA Polymerase

Saiki, R. K., Gelfand, D. H., Stoffel, S., Scharf, S. J., Higuchi, R., Horn, G. T., Mullis, K. B., & Erlich, H. A. (1988) · Science · doi:10.1126/science.2448875 · Cited by 17,719

Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators

Issemann, I., & Green, S. (1990) · Nature · doi:10.1038/347645a0 · Cited by 3,519

Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors

Dreyer, C., Krey, G. D., Keller, H., Givel, F., Helftenbein, G., & Wahli, W. (1992) · Cell · doi:10.1016/0092-8674(92)90031-7 · Cited by 1,393

The mouse peroxisome proliferator activated receptor recognizes a response element in the 5′ flanking sequence of the rat acyl CoA oxidase gene

Tugwood, J. D., Issemann, I., Anderson, R. G., Bundell, K. R., McPheat, W. L., & Green, S. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05072.x · Cited by 895

Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens

Reddy, J. K., Azarnoff, D. L., & Hignite, C. E. (1980) · Nature · doi:10.1038/283397a0 · Cited by 835

NATURE OF THE HEPATOMEGALIC EFFECT PRODUCED BY ETHYL-CHLOROPHENOXY-ISOBUTYRATE IN THE RAT

Hess, R., Stäubli, W., & RIESS, W. (1965) · Nature · doi:10.1038/208856a0 · Cited by 596

Targeted Disruption of the α Isoform of the Peroxisome Proliferator-Activated Receptor Gene in Mice Results in Abolishment of the Pleiotropic Effects of Peroxisome Proliferators

Lee, S. S. T., Pineau, T., Drago, J., Lee, E. J., Owens, J. W., Kroetz, D. L., Fernández‐Salguero, P. M., Westphal, H., & Gonzalez, F. J. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.6.3012 · Cited by 1,652

Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression

Schoonjans, K., Staels, B., & Auwerx, J. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42003-6 · Cited by 1,216

The peroxisome proliferator activated receptors (PPARs) and their effects on lipid metabolism and adipocyte differentiation

Schoonjans, K., Staels, B., & Auwerx, J. H. (1996) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(96)00066-5 · Cited by 1,045

The peroxisome proliferator-activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression.

Gulick, T., Cresci, S., Caira, T., Moore, D. D., & Kelly, D. P. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.11012 · Cited by 567

Fatty Acids Activate Transcription of the Muscle Carnitine Palmitoyltransferase I Gene in Cardiac Myocytes via the Peroxisome Proliferator-activated Receptor α

Brandt, J. M., Djouadi, F., & Kelly, D. P. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.37.23786 · Cited by 458

Fructose: a highly lipogenic nutrient implicated in insulin resistance, hepatic steatosis, and the metabolic syndrome

Dekker, M. J., Su, Q., Baker, C., Rutledge, A. C., & Adeli, K. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00283.2010 · Cited by 432

Inhibition of Human Lung Cancer Cell Growth by the Peroxisome Proliferator-Activated Receptor-γ Agonists through Induction of Apoptosis

Tsubouchi, Y., Sano, H., Kawahito, Y., Mukai, S., Yamada, R., Kohno, M., Inoue, K., Hla, T., & Kondo, M. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2436 · Cited by 312

Diverse compounds mimic Alzheimer disease–causing mutations by augmenting Aβ42 production

Kukar, T. L., Murphy, M. P., Eriksen, J. L., Sagi, S. A., Weggen, S., Smith, T. E., Ladd, T. B., Khan, M. A., Kache, R., Beard, J. D., et al. (2005) · Nature Medicine · doi:10.1038/nm1235 · Cited by 290

The ligands/activators for peroxisome proliferator-activated receptor α (PPARα) and PPARγ increase Cu2+, Zn2+-superoxide dismutase and decrease p22phox message expressions in primary endothelial cells

Inoue, I., Goto, S.-I., Matsunaga, T., Nakajima, T., Awata, T., Hokari, S., Komoda, T., & Katayama, S. (2001) · Metabolism · doi:10.1053/meta.2001.19415 · Cited by 283

Peroxisome proliferators and peroxisome proliferator activated receptors (PPARs) as regulators of lipid metabolism

Latruffe, N., & Vamecq, J. (1997) · Biochimie · doi:10.1016/s0300-9084(97)81496-4 · Cited by 235

Peroxisome proliferator and retinoid signalingpathways co-regulate preadipocyte phenotype and survival.

Chawla, A., & Lazar, M. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.5.1786 · Cited by 230

Impairment of hepatic Stat-3 activation and reduction of PPARα activity in fructose-fed rats

Roglans, N., Vilà, L., Farré, M., Alegret, M., Sánchez, R. M., Vázquez‐Carrera, M., & Laguna, J. C. (2007) · Hepatology · doi:10.1002/hep.21499 · Cited by 226

A role for Sp and nuclear receptor transcription factors in a cardiac hypertrophic growth program

Sack, M. N., Disch, D. L., Rockman, H. A., & Kelly, D. P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6438 · Cited by 206

Expression of Peroxisome Proliferator-Activated Receptor α (PPARα) in Primary Cultures of Human Vascular Endothelial Cells

Inoue, I., Shino, K., Noji, S., Awata, T., & Katayama, S. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8622 · Cited by 202

Pilot study: fenofibrate for patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid: Pilot study: fenofibrate with UDCA for primary biliary cirrhosis

Levy, C., Peter, J. A., Nelson, D. R., Keach, J., Petz, J., Cabrera, R., Clark, V., Firpi, R. J., Morelli, G., Soldevila-Pico, C., et al. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04512.x · Cited by 186

Effect of endurance training on lipid metabolism in women: a potential role for PPARα in the metabolic response to training

Horowitz, J. F., Leone, T. C., Feng, W., Kelly, D. P., & Klein, S. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.279.2.e348 · Cited by 181

Hypoxia Inhibits the Peroxisome Proliferator-activated Receptor α/ Retinoid X Receptor Gene Regulatory Pathway in Cardiac Myocytes

Huss, J. M., Levy, F. H., & Kelly, D. P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100277200 · Cited by 174

Role of peroxisome proliferator-activated receptor α in disease of pancreatic β cells

Zhou, Y.-T., Shimabukuro, M., Wang, M.-Y., Lee, Y., Higa, M., Milburn, J. L., Newgard, C. B., & Unger, R. H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8898 · Cited by 173

Role of peroxisome proliferator-activated receptor alpha in altered cell cycle regulation in mouse liver

Peters, J. M. (1998) · Carcinogenesis · doi:10.1093/carcin/19.11.1989 · Cited by 160

Asp333, Asp495, and His52.3 Form the Catalytic Triad of Rat Soluble Epoxide Hydrolase

Arand, M., Wagner, H., & Oesch, F. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.8.4223 · Cited by 138

Sex Difference in Hepatic Peroxisome Proliferator-Activated Receptor α Expression: Influence of Pituitary and Gonadal Hormones

Jalouli, M., Carlsson, L., Améen, C., Lindén, D., Ljungberg, A., Michalik, L., Edén, S., Wahli, W., & Oscarsson, J. (2002) · Endocrinology · doi:10.1210/en.2002-220630 · Cited by 131

Transcriptional and phenotypic comparisons of Ppara knockout and siRNA knockdown mice

Souza, A. T. D., Dai, X., Spencer, A. G., Reppen, T. W., Menzie, A. M., Roesch, P. L., He, Y. D., Caguyong, M. J., Bloomer, S., Herweijer, H., et al. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl609 · Cited by 110

Activation of a human peroxisome proliferator-activated receptor by the antitumor agent phenylacetate and its analogs

Pineau, T., Hudgins, W. R., Liu, L., Chen, L., Sher, T., Gonzalez, F. J., & Samid, D. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(96)00340-1 · Cited by 110

Acyl‐CoA synthetase mRNA expression is controlled by fibric‐acid derivatives, feeding and liver proliferation

Schoonjans, K., Staels, B., Grimaldi, P. A., & Auwerx, J. H. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb18181.x · Cited by 109

Bezafibrate normalizes alkaline phosphatase in primary biliary cirrhosis patients with incomplete response to ursodeoxycholic acid

Lens, S., Leoz, M., Nazal, L., Bruguera, M., & Parés, A. (2014) · Liver International · doi:10.1111/liv.12290 · Cited by 107

Fenofibrate for patients with asymptomatic primary biliary cirrhosis

Dohmen, K., Mizuta, T., Nakamuta, M., Shimohashi, N., Ishibashi, H., & Yamamoto, K. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i6.894 · Cited by 99

Central role of PPARα in the mechanism of action of hepatocarcinogenic peroxisome proliferators

Corton, J. C., Lapinskas, P. J., & Gonzalez, F. J. (2000) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(99)00232-8 · Cited by 99

Lipid Metabolism and Insulin Resistance in Depressed Patients: Significance of Weight, Hypercortisolism, and Antidepressant Treatment

Kopf, D., Westphal, S., Luley, C. W., Ritter, S., Gilles, M., Weber-Hamann, B., Lederbogen, F., Lehnert, H., Henn, F. A., Heuser, I., et al. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000138762.23482.63 · Cited by 92

Influence of Peroxisome Proliferator-activated Receptor α Agonists on the Intracellular Turnover and Secretion of Apolipoprotein (Apo) B-100 and ApoB-48

Lindén, D., Lindberg, K., Oscarsson, J., Claesson, C., Asp, L., Lu, L., Gustafsson, M. V., Borén, J., & Olofsson, S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110416200 · Cited by 92

Neuroprotective effects of peroxisome proliferator-activated receptor alpha and gamma agonists in model of parkinsonism induced by intranigral 1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine

Barbiero, J. K., Santiago, R. M., Persike, D. S., Fernandes, M. J. D. S., Tonin, F. S., Cunha, C. D., Boschen, S. L., Lima, M. M. S., & Vital, M. A. B. F. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.08.014 · Cited by 91

Expression of peroxisome proliferator-activated receptors in zebrafish (Danio rerio) depending on gender and developmental stage

Ibabe, A., Bilbao, E., & Cajaraville, M. P. (2004) · Histochemistry and Cell Biology · doi:10.1007/s00418-004-0737-2 · Cited by 83

Effects of green tea on insulin sensitivity, lipid profile and expression of PPARα and PPARγ and their target genes in obese dogs

Serisier, S., Leray, V., Poudroux, W., Magot, T., Ouguerram, K., & Nguyen, P. (2007) · British Journal Of Nutrition · doi:10.1017/s0007114507862386 · Cited by 80

Chromosomal Localisation, Inducibility, Tissue‐Specific Expression and Strain Differences in Three Murine Peroxisome‐Proliferator‐Activated‐Receptor Genes

Jones, P. S., Savory, R., Barratt, P., Bell, A. R., Gray, T. J. B., Jenkins, N. A., Gilbert, D. J., Copeland, N. G., & Bell, D. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.219_1.x · Cited by 79

Liver-Specific Peroxisome Proliferator–Activated Receptor α Target Gene Regulation by the Angiotensin Type 1 Receptor Blocker Telmisartan

Clemenz, M., Frost, N., Schupp, M., Caron, S., Foryst‐Ludwig, A., Böhm, C., Hartge, M., Gust, R., Staels, B., Unger, T., et al. (2008) · Diabetes · doi:10.2337/db07-0839 · Cited by 79

Effect of Fenofibrate on Uric Acid Metabolism and Urate Transporter 1

Uetake, D., Ohno, I., Ichida, K., Yamaguchi, Y., Saikawa, H., Endou, H., & Hosoya, T. (2010) · Internal Medicine · doi:10.2169/internalmedicine.49.2597 · Cited by 73

Fenofibrate modifies transaminase gene expression via a peroxisome proliferator activated receptor α-dependent pathway

Edgar, A. D., Tomkiewicz, C., Costet, P., Legendre, C., Aggerbeck, M., Bouguet, J., Staels, B., Guyomard, C., Pineau, T., & Barouki, R. (1998) · Toxicology Letters · doi:10.1016/s0378-4274(98)00042-3 · Cited by 71

Micronized Fenofibrate: A New Fibric Acid Hypolipidemic Agent

Guay, D. R. P. (1999) · Annals of Pharmacotherapy · doi:10.1345/aph.18432 · Cited by 69

PPARα regulates the hepatotoxic biomarker alanine aminotransferase (ALT1) gene expression in human hepatocytes

Thulin, P., Rafter, I., Stockling, K., Tomkiewicz, C., Norjavaara, E., Aggerbeck, Μ., Hellmold, H., Ehrenborg, E., Andersson, U., Cotgreave, I. A., et al. (2008) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2008.03.007 · Cited by 68

Activation of a novel metabolic gene regulatory pathway by chronic stimulation of skeletal muscle

Cresci, S., Wright, L. D., Spratt, J. A., Briggs, F. N., & Kelly, D. P. (1996) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1996.270.5.c1413 · Cited by 69

Peroxisome Proliferator-Activated Receptor (PPAR): Structure, Mechanisms of Activation and Diverse Functions.

Motojima, K. (1993) · Cell Structure and Function · doi:10.1247/csf.18.267 · Cited by 64

Visualization of a Covalent Intermediate between Microsomal Epoxide Hydrolase, but not Cholesterol Epoxide Hydrolase, and their Substrates

Müller, F. U., Arand, M., Frank, H., Seidel, A., Hinz, W., Winkler, L., Hänel, K., Blée, E., Beetham, J. K., Hammock, B. D., et al. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00490.x · Cited by 59

Inhibition of the aryl hydrocarbon receptor/polyamine biosynthesis axis suppresses multiple myeloma

Bianchi, A., Bagati, A., Fink, E. E., Affronti, H. C., Lipchick, B. C., Moparthy, S., Long, M. D., Rosario, S. R., Lightman, S. M., Moparthy, K., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci70712 · Cited by 57

Evaluation of childhood exposure to di(2-ethylhexyl) phthalate from perfusion kits during long-term parenteral nutrition

Kambia, K., Dine, T., Gressier, B., Bah, S., Germe, A.-F., Luyckx, M., Brunet, C., Michaud, L., & Gottrand, F. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00335-1 · Cited by 54

The role of nuclear receptors in regulation of Th17/Treg biology and its implications for diseases

Park, B. V., & Pan, F. (2015) · Cellular and Molecular Immunology · doi:10.1038/cmi.2015.21 · Cited by 50

Dietary Corosolic Acid Ameliorates Obesity and Hepatic Steatosis in KK-Ay Mice

Yamada, K., Hosokawa, M., Yamada, C., Watanabe, R., Fujimoto, S., Fujiwara, H., Kunitomo, M., Miura, T., Kaneko, T., Tsuda, K., et al. (2008) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.31.651 · Cited by 49

Effect on the expression of c-met, c-myc and PPAR-α in liver and liver tumors from rats chronically exposed to the hepatocarcinogenic peroxisome proliferator WY-14, 643

Miller, R. T., Glover, S. E., Stewart, W. S., Corton, J. C., Popp, J. A., & Cattley, R. C. (1996) · Carcinogenesis · doi:10.1093/carcin/17.6.1337 · Cited by 47

Expression of peroxisome proliferator-activated receptors in the liver of gray mullet (Mugil cephalus)

Ibabe, A., Grabenbauer, M., Baumgart‐Vogt, E., Völkl, A., Fahimi, H. D., & Cajaraville, M. P. (2004) · Acta Histochemica · doi:10.1016/j.acthis.2003.09.002 · Cited by 46

Peroxisome Proliferators: Their Biological and Toxicological Effects

Dzhekova-Stojkova, S., Bogdanska, J., & Stojkova, Z. (2001) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2001.076 · Cited by 44

Diphenylmethane skeleton as a multi-template for nuclear receptor ligands: Preparation of FXR and PPAR ligands

Kainuma, M., Kasuga, J.-I., Hosoda, S., Wakabayashi, K.-I., Tanatani, A., Nagasawa, K., Miyachi, H., Makishima, M., & Hashimoto, Y. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.03.075 · Cited by 41

Fenofibrate and metabolic syndrome

T. Kraja, A., A. Province, M., J. Straka, R., M. Ordovas, J., B. Borecki, I., & K. Arnett, D. (2010) · Endocrine, Metabolic & Immune Disorders - Drug Targets · doi:10.2174/187153010791213047 · Cited by 40

Hepatic regeneration in peroxisome proliferator-activated receptor α-null mice after partial hepatectomy

Rao, M. S. R. (2002) · Hepatology Research · doi:10.1016/s1386-6346(01)00119-x · Cited by 40

Regulation of CYP4A1 and peroxisome proliferator-activated receptor alpha expression by interleukin Iβ, interleukhv 6, and dexamethasone in cultured fetal rat hepatocytes

Parmentier, J. H., Schohn, H., Bronner, M., Ferrari, L., Batt, A. M., Dauça, M., & Kremers, P. G. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00256-6 · Cited by 39

Peroxisome Proliferator‐Activated Receptors: Potential Therapeutic Targets in Lung Disease?

Denning, G. M., & Stoll, L. L. (2005) · Pediatric Pulmonology · doi:10.1002/ppul.20338 · Cited by 37

Monascin improves diabetes and dyslipidemia by regulating PPARγ and inhibiting lipogenesis in fructose-rich diet-induced C57BL/6 mice

Lee, B., Hsu, W.-H., Huang, T., Chang, Y., Hsu, Y.-W., & Pan, T. (2013) · Food & Function · doi:10.1039/c3fo60062a · Cited by 31

Biological regulation of receptor-hormone complex concentrations in relation to dose-response assessments for endocrine-active compounds

Andersen, M. E., & Barton, H. A. (1999) · Toxicological Sciences · doi:10.1093/toxsci/48.1.38 · Cited by 30

Activating Effect of Benzbromarone, a Uricosuric Drug, on Peroxisome Proliferator-Activated Receptors

Kunishima, C., Inoue, I., Oikawa, T., Nakajima, H., Komoda, T., & Katayama, S. (2007) · PPAR Research · doi:10.1155/2007/36092 · Cited by 29

Fraudulent (and non fraudulent) fatty acids for human health

Sirtori, C. R., Galli, C., & Franceschini, G. (1993) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1993.tb01286.x · Cited by 28

Expression of peroxisome proliferator‐activated receptors alpha and gamma in differentiating human colon carcinoma Caco‐2 cells

Huin‐Schohn, C., Schohn, H., Hatier, R., Bentéjac, M., Antunes, L., Plénat, F., Bugaut, M., & Dauça, M. (2002) · Biology of the Cell · doi:10.1016/s0248-4900(01)01178-9 · Cited by 27

The diagnosis and treatment of primary biliary cirrhosis

Kim, K., & Jeong, S. (2011) · The Korean Journal of Hepatology · doi:10.3350/kjhep.2011.17.3.173 · Cited by 25

Low-level self-tolerance to arsenite in human HepG2 cells is associated with a depressed induction of micronuclei

Gebel, T., Leister, M., Schumann, W., & Hirsch‐Ernst, K. I. (2002) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/s1383-5718(01)00343-6 · Cited by 24

Effectiveness of fenofibrate in comparison to bezafibrate for patients with asymptomatic primary biliary cirrhosis.

Dohmen, K., Tanaka, H., & Haruno, M. (2013) · PubMed · doi:10.15017/1398604 · Cited by 24

IL-17A-targeting fenofibrate attenuates inflammation in psoriasis by inducing autophagy

Park, A., & Heo, T. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121755 · Cited by 22

Peroxisome Proliferator-Activated Receptor ?? and Hypertensive Heart Disease

Goikoetxea, M. J., Beaumont, J., & ez, J. D. (2004) · Drugs · doi:10.2165/00003495-200464002-00003 · Cited by 21

Effects of Switching from Fenofibrate to Pemafibrate for Asymptomatic Primary Biliary Cholangitis

Dohmen, K., Onohara, S.-Y., & Harada, S. (2021) · The Korean Journal of Gastroenterology · doi:10.4166/kjg.2021.092 · Cited by 18

The transcription of the peroxisome proliferator-activated receptor α gene is regulated by protein kinase C

Yaacob, N.-S., Norazmi, M. N., Gibson, G. G., & Kass, G. E. N. (2001) · Toxicology Letters · doi:10.1016/s0378-4274(01)00433-7 · Cited by 18

Ciglitizone and 15d PGJ2 induce apoptosis in Jurkat and Raji cells.

Kanunfre, C., Freitas, J. J. D. S., Pompéia, C., de Almeida, D. C. G., Cury-Boaventura, M., Verlengia, R., & Curi, R. (2004) · International Immunopharmacology · doi:10.1016/j.intimp.2004.05.007 · Cited by 16

Decreased expression of peroxisome proliferator‐activated receptor α and liver fatty acid binding protein after partial hepatectomy of rats and mice

Skrtic, S., Carlsson, L., Ljungberg, A., Lindén, D., Michalik, L., Wahli, W., & Oscarsson, J. (2005) · Liver International · doi:10.1111/j.1478-3231.2004.0998.x · Cited by 17

In vivo stabilization of nuclear retinoid X receptor α in the presence of peroxisome proliferator‐activated receptor α

Tanaka, N., Hora, K., Makishima, H., Kamijo, Y., Kiyosawa, K., Gonzalez, F. J., & Aoyama, T. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00423-x · Cited by 16

The pesticide adjuvant, Toximul™, alters hepatic metabolism through effects on downstream targets of PPARα

Upham, J. P., Acott, P. D., O’Regan, P. A., Sinal, C. J., Crocker, J. F. S., Geldenhuys, L., & Murphy, M. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2007.06.003 · Cited by 14

The effects of Eucalyptus terpenes on hepatic cytochrome P450 CYP4A, peroxisomal Acyl CoA oxidase (AOX) and peroxisome proliferator activated receptor alpha (PPARα) in the common brush tail possum (Trichosurus vulpecula)

Ngo, S. N. T., McKinnon, R. A., & Stupans, I. (2003) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/s1532-0456(03)00197-2 · Cited by 14

Hypertriglyceridemia and Hepatic Steatosis in Senescence-Accelerated Mouse Associate to Changes in Lipid-Related Gene Expression

Vilà, L., Roglans, N., Alegret, M., Camins, A., Pallàs, M., Sánchez, R. M., Vázquez‐Carrera, M., & Laguna, J. C. (2007) · The Journals of Gerontology Series A · doi:10.1093/gerona/62.11.1219 · Cited by 14

Reduction of palmitate-induced cardiac apoptosis by fenofibrate

Kong, J. Y., & Rabkin, S. W. (2004) · Molecular and Cellular Biochemistry · doi:10.1023/b:mcbi.0000012811.89386.a8 · Cited by 13

Role of Thyroid Hormones in Hepatic Effects of Peroxisome Proliferators

Miller, R. T., Scappino, L. A., Long, S. M., & Corton, J. C. (2001) · Toxicologic Pathology · doi:10.1080/019262301301418964 · Cited by 13

Triglyceridemia and peroxisome proliferator- activated receptor-α expression are not connected in fenofibrate-treated pregnant rats

Soria, A., González, M. D. C., Vidal, H., Herrera, E., & Bocos, C. (2005) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-005-8145-z · Cited by 13

NSAID-derived γ-secretase modulators. Part III: Membrane anchoring

Baumann, S., Höttecke, N., Schubenel, R., Baumann, K., & Schmidt, B. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.10.035 · Cited by 12

Effect of a pharmacological activation of PPAR on the expression of RAR and TR in rat liver

Bonilla, S., Redonnet, A., Nöel-Suberville, C., Groubet, R., Pallet, V., & Higueret, P. (2001) · Journal of Physiology and Biochemistry · doi:10.1007/bf03179807 · Cited by 12

Pparα knockout in mice increases the Th17 development by facilitating the IKKα/RORγt and IKKα/Foxp3 complexes

Wei, P., Kou, W., Fu, J. L., Chen, Z., & Pan, F. (2023) · Communications Biology · doi:10.1038/s42003-023-05104-6 · Cited by 12

Peroxisome proliferators as inducers and substrates of UDP‐glucuronosyltransferases

Magdalou, J., Fournel‐Gigleux, S., Pritchard, M. P., & Siest, G. (1993) · Biology of the Cell · doi:10.1016/s0248-4900(05)80169-8 · Cited by 9

Clofibrate and other peroxisomal proliferating agents relatively specifically inhibit synthesis of ethanolamine phosphoglycerides in cultured human fibroblasts

Thorne, P., Byers, D. M., Palmer, F. B. S. C., & Cook, H. W. (1994) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(94)90040-x · Cited by 9

Hepatic nuclear receptor PPARα in the koala (Phascolarctos cinereus): Cloning and molecular characterisation

Ngo, S. N. T., McKinnon, R. A., & Stupans, I. (2007) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cbpc.2007.04.013 · Cited by 8

Tissue-Specific 5′ Heterogeneity of PPARα Transcripts and Their Differential Regulation by Leptin

Garratt, E. S., Vickers, M. H., Gluckman, P. D., Hanson, M. A., Burdge, G. C., & Lillycrop, K. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067483 · Cited by 8

Evidence for a Novel Cardiac-enriched Retinoid X Receptor Partner

Cresci, S., Clabby, M. L., & Kelly, D. P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.36.25668 · Cited by 8

Differential modulation of PPARα and γ target gene expression in the liver and kidney of rats treated with aspirin

Fidaleo, M., Berardi, E., & Sartori, C. (2008) · Experimental and Toxicologic Pathology · doi:10.1016/j.etp.2007.11.011 · Cited by 7

Biochemical properties of liver peroxisomes from rat, guinea pig and human species and the influence of hormonal status on rat liver acyl-CoA oxidase mRNA content

Pacot, C., & Latruffe, N. (1993) · Biochimie · doi:10.1016/0300-9084(93)90082-4 · Cited by 7

Differential induction of rat hepatic microsomal and peroxisomal long-chain and nafenopin-CoA ligases by clofibric acid and di-(2-ethylhexyl)phthalate

Roberts, B. J., & Knights, K. M. (1995) · Xenobiotica · doi:10.3109/00498259509061866 · Cited by 7

Study Design and Protocol for a Randomized Controlled Trial to Assess Long-Term Efficacy and Safety of a Triple Combination of Ezetimibe, Fenofibrate, and Moderate-Intensity Statin in Patients with Type 2 Diabetes and Modifiable Cardiovascular Risk Factors (ENSEMBLE)

Kim, N. H., Lee, J., Chon, S., Yu, J. M., Jeong, I., Lim, S. K., Kim, W. J., Song, K., Cho, H., Yu, H. M., et al. (2024) · Endocrinology and Metabolism · doi:10.3803/enm.2024.1995 · Cited by 6

Nuevos receptores nucleares heterodiméricos: reguladores metabólicos con impacto en fisiopatología y su proyección terapéutica en dislipidemias y diabetes mellitus

Cortés, V., Quezada, N., Rigotti, A., & Alberto Maiz, G. (2005) · Revista médica de Chile · doi:10.4067/s0034-98872005001200011 · Cited by 6

Steroid Hormones and other Physiologic Regulators of Liver Cytochromes P450: Metabolic Reactions and Regulatory Pathways

Waxman, D. J. (1996) · Advances in molecular and cell biology · doi:10.1016/s1569-2558(08)60349-5 · Cited by 6

Avances en cardiopatía hipertensiva. Mecanismos de remodelado implicados en la transición de la hipertrofia a la insuficiencia cardiaca

Beaumont, J., Arias, T., López, B., González, A., Ravassa, S., Hermida, N., Querejeta, R., & Dı́ez, J. (2007) · Revista Española de Cardiología Suplementos · doi:10.1016/s1131-3587(07)75252-4 · Cited by 5

Induction of the expression of the peroxisome proliferator‐activated receptor alpha (PPARα) by clofibrate in jerboa tissues

Amsaguine, S., Bianchi, A., Collet, P., Huin‐Schohn, C., Jeanvoine, A., Bécuwe, P., Krémarik, P., Domenjoud, L., Keller, J. M., Schohn, H., et al. (2003) · Microscopy Research and Technique · doi:10.1002/jemt.10328 · Cited by 5

Therapeutic potential of PPARα agonist in ligature-induced experimental periodontitis

Chen, Y., & Hu, Y. (2022) · Journal of Applied Oral Science · doi:10.1590/1678-7757-2021-0648 · Cited by 4

Reducción en la actividad de transactivación y transrepresión de PPARα en un modelo experimental de síndrome metabólico por fructosa dietética

Roglans, N., Vilà, L., & Laguna, J. C. (2007) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/s0214-9168(07)74165-7 · Cited by 4

Biochemical and Histological Effectiveness of Long-term Use of Fenofibrate for Asymptomatic Primary Biliary Cholangitis

Dohmen, K., Tanaka, H., Haruno, M., & Aishima, S. (2016) · Journal of Gastroenterology and Hepatology Research · doi:10.17554/j.issn.2224-3992.2016.05.635 · Cited by 3

Ciprofibrate regulation of rat hepatic bilirubin glucuronidation and UDP-glucuronosyltransferases expression

Heydel, J., Garnier, P. E., Fauré, P., & Artur, Y. (2012) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/s13318-012-0091-z · Cited by 3

Regulation of Elovl and fatty acid metabolism

Brolinson, A. (2009) · KTH Publication Database DiVA (KTH Royal Institute of Technology) · Cited by 3

Dose-related effects of the peroxisome proliferator methylclofenapate in rat liver

Lake, B. G., Rumsby, P. C., Cunninghame, M. E., & Price, R. J. (2002) · Environmental Toxicology and Pharmacology · doi:10.1016/s1382-6689(01)00116-8 · Cited by 2

Molecular toxicology of peroxisome proliferators

McNae, F., Sharma, R. K., & Gibson, G. G. (1994) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/bf03188924 · Cited by 2

Malic enzyme gene in chick embryo hepatocytes in culture: clofibrate regulates responsiveness to triiodothyronine

Carlisle, T. L., Roncero, C., Mounier, C., Thurmond, D. C., & Goodridge, A. G. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37291-6 · Cited by 2

Induction of propranolol metabolism in isolated rats hepatocytes treated by di(2-ethylhexyl) phthalate (DEHP) and mono(2-ethylhexyl) phthalate (MEHP)

Kambia, K., Dine, T., Gressier, B., Benaji, B., Faouzi, M. E. A., Dupin-Spriet, T., Luyckx, M., & Brunet, C. (2003) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/bf03190488 · Cited by 1

Age-related effects of fenofibrate on the hepatic expression of sirtuin 1, sirtuin 3, and lipid metabolism-related genes

Zubrzycki, A., Wrońska, A., Wierzbicki, P. M., & Kmieć, Z. (2023) · Acta Biochimica Polonica · doi:10.18388/abp.2020_6538 · Cited by 1

Transcriptional induction of the fatty acid binding protein gene in mouse liver by bezafibrate

Besnard, P., Mallordy, A., & CARLIER, H. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)80173-r · Cited by 46

Fenofibrate, a peroxisome proliferator-activated receptor α-agonist, blocks lipopolysaccharide-induced inflammatory pathways in mouse liver

Won, T. W. (2013) · Korean Journal of Hepato-Biliary-Pancreatic Surgery · doi:10.14701/kjhbps.2013.17.3.89 · Cited by 18

Peroxisome proliferator activated receptor-alpha (PPAR-alpha) expression is induced but peroxisomal enzyme response to clofibrate is blunted in a rat model of fatty liver

Akbıyık, F., Cinar, K., Ozsullu, T., Demirpençe, E., Tunca, R., Haziroglu, R., Önder, O. K., Civris, S., Yurdaydın, C., Uzunalımoǧlu, Ö., et al. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)80500-7 · Cited by 1

Addition of peroxisome proliferator-activated receptor alpha to guinea pig hepatocytes confers increased responsiveness to peroxisome proliferators.

Macdonald, N., Holden, P. R., & Roberts, R. A. (1999) · PubMed · Cited by 19

Comparative effect of fenofibrate on hepatic desaturases in wild‐type and peroxisome proliferator‐activated receptor α‐deficient mice

Guillou, H., Martin, P. G. P., Jan, S., d’Andrea, S., Roulet, A., Catheline, D., Rioux, V., Pineau, T., & Legrand, P. (2002) · Lipids · doi:10.1007/s11745-006-0990-3 · Cited by 43